CD133 Marrow Cell Injection

· German Heart Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD133 Marrow Cell Injection, covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure [Phase 2, Phase 3]